At 36 weeks, fasting plasma insulin was determined (Fig. 1D) and, as anticipated, DIO mice displayed robust hyperinsulinemia, with a 4.7-fold increase in insulin compared to SD mice. The gene discussed is INS; the disease is hyperinsulinism.